181 related articles for article (PubMed ID: 29477147)
1. MicroRNA-19a contributes to the epigenetic regulation of tissue factor in diabetes.
Witkowski M; Tabaraie T; Steffens D; Friebel J; Dörner A; Skurk C; Witkowski M; Stratmann B; Tschoepe D; Landmesser U; Rauch U
Cardiovasc Diabetol; 2018 Feb; 17(1):34. PubMed ID: 29477147
[TBL] [Abstract][Full Text] [Related]
2. Micro-RNA-126 Reduces the Blood Thrombogenicity in Diabetes Mellitus via Targeting of Tissue Factor.
Witkowski M; Weithauser A; Tabaraie T; Steffens D; Kränkel N; Witkowski M; Stratmann B; Tschoepe D; Landmesser U; Rauch-Kroehnert U
Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1263-71. PubMed ID: 27127202
[TBL] [Abstract][Full Text] [Related]
3. Vascular miR-181b controls tissue factor-dependent thrombogenicity and inflammation in type 2 diabetes.
Witkowski M; Witkowski M; Saffarzadeh M; Friebel J; Tabaraie T; Ta Bao L; Chakraborty A; Dörner A; Stratmann B; Tschoepe D; Winter SJ; Krueger A; Ruf W; Landmesser U; Rauch U
Cardiovasc Diabetol; 2020 Feb; 19(1):20. PubMed ID: 32066445
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-223 inhibits tissue factor expression in vascular endothelial cells.
Li S; Chen H; Ren J; Geng Q; Song J; Lee C; Cao C; Zhang J; Xu N
Atherosclerosis; 2014 Dec; 237(2):514-20. PubMed ID: 25463083
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-19a targets tissue factor to inhibit colon cancer cells migration and invasion.
Yu G; Li H; Wang X; Wu T; Zhu J; Huang S; Wan Y; Tang J
Mol Cell Biochem; 2013 Aug; 380(1-2):239-47. PubMed ID: 23666757
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1α and Cathepsin G.
Folco EJ; Mawson TL; Vromman A; Bernardes-Souza B; Franck G; Persson O; Nakamura M; Newton G; Luscinskas FW; Libby P
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1901-1912. PubMed ID: 29976772
[TBL] [Abstract][Full Text] [Related]
7. Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes.
Witkowski M; Friebel J; Tabaraie T; Grabitz S; Dörner A; Taghipour L; Jakobs K; Stratmann B; Tschoepe D; Landmesser U; Rauch U
Cardiovasc Drugs Ther; 2021 Aug; 35(4):809-813. PubMed ID: 32940892
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-19b functions as potential anti-thrombotic protector in patients with unstable angina by targeting tissue factor.
Li S; Ren J; Xu N; Zhang J; Geng Q; Cao C; Lee C; Song J; Li J; Chen H
J Mol Cell Cardiol; 2014 Oct; 75():49-57. PubMed ID: 24998411
[TBL] [Abstract][Full Text] [Related]
9. miR-19a-3p downregulates tissue factor and functions as a potential therapeutic target for sepsis-induced disseminated intravascular coagulation.
Zhang R; Lu S; Yang X; Li M; Jia H; Liao J; Jing Q; Wu Y; Wang H; Xiao F; Bai X; Na X; Kang Y; Wan L; Yang J
Biochem Pharmacol; 2021 Oct; 192():114671. PubMed ID: 34246626
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-145 Impedes Thrombus Formation via Targeting Tissue Factor in Venous Thrombosis.
Sahu A; Jha PK; Prabhakar A; Singh HD; Gupta N; Chatterjee T; Tyagi T; Sharma S; Kumari B; Singh S; Nair V; Goel S; Ashraf MZ
EBioMedicine; 2017 Dec; 26():175-186. PubMed ID: 29217135
[TBL] [Abstract][Full Text] [Related]
11. Sirt1 inhibition promotes in vivo arterial thrombosis and tissue factor expression in stimulated cells.
Breitenstein A; Stein S; Holy EW; Camici GG; Lohmann C; Akhmedov A; Spescha R; Elliott PJ; Westphal CH; Matter CM; Lüscher TF; Tanner FC
Cardiovasc Res; 2011 Feb; 89(2):464-72. PubMed ID: 20978007
[TBL] [Abstract][Full Text] [Related]
12. Estradiol-Responsive miR-365a-3p Interacts with Tissue Factor 3'UTR to Modulate Tissue Factor-Initiated Thrombin Generation.
Tian J; Adams MJ; Tay JWT; James I; Powell S; Hughes QW; Gilmore G; Baker RI; Tiao JY
Thromb Haemost; 2021 Nov; 121(11):1483-1496. PubMed ID: 33540457
[TBL] [Abstract][Full Text] [Related]
13. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
[TBL] [Abstract][Full Text] [Related]
14. Does hsa-miR-223-3p from platelet-derived extracellular vesicles regulate tissue factor expression in monocytic cells?
Collier MEW; Ambrose AR; Goodall AH
Platelets; 2022 Oct; 33(7):1031-1042. PubMed ID: 35132909
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA Microarray-Based Identification of Involvement of miR-155 and miR-19a in Development of Oral Lichen Planus (OLP) by Modulating Th1/Th2 Balance via Targeting eNOS and Toll-Like Receptor 2 (TLR2).
Wang L; Wu W; Chen J; Li Y; Xu M; Cai Y
Med Sci Monit; 2018 May; 24():3591-3603. PubMed ID: 29813046
[TBL] [Abstract][Full Text] [Related]
16. Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions.
Long J; Wang Y; Wang W; Chang BH; Danesh FR
J Biol Chem; 2010 Jul; 285(30):23457-65. PubMed ID: 20501654
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-19a regulates lipopolysaccharide-induced endothelial cell apoptosis through modulation of apoptosis signal-regulating kinase 1 expression.
Jiang WL; Zhang YF; Xia QQ; Zhu J; Yu X; Fan T; Wang F
BMC Mol Biol; 2015 May; 16():11. PubMed ID: 25982447
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-19a inhibits colorectal cancer angiogenesis by suppressing KRAS expression.
Chen M; Lin M; Wang X
Oncol Rep; 2018 Feb; 39(2):619-626. PubMed ID: 29207158
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus.
Jansen F; Wang H; Przybilla D; Franklin BS; Dolf A; Pfeifer P; Schmitz T; Flender A; Endl E; Nickenig G; Werner N
Cardiovasc Diabetol; 2016 Mar; 15():49. PubMed ID: 27005938
[TBL] [Abstract][Full Text] [Related]
20. Endothelial connexin 32 regulates tissue factor expression induced by inflammatory stimulation and direct cell-cell interaction with activated cells.
Okamoto T; Akita N; Hayashi T; Shimaoka M; Suzuki K
Atherosclerosis; 2014 Oct; 236(2):430-7. PubMed ID: 25171777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
